Literature DB >> 10520832

Prevalence and impact of upper gastrointestinal symptoms in the Canadian population: findings from the DIGEST study. Domestic/International Gastroenterology Surveillance Study.

G Tougas1, Y Chen, P Hwang, M M Liu, A Eggleston.   

Abstract

OBJECTIVE: The prevalence and impact of upper gastrointestinal (GI) symptoms in the general population are poorly defined. Most data are obtained from selected samples derived from patients presenting to health care providers. As part of a larger international effort (The DIGEST study), we examined the prevalence of upper GI symptoms among the general Canadian population, as well as their psychosocial and economic impact.
METHODS: A sample of 1036 adults was studied, its demographic characteristics closely matching those of the general Canadian population. A validated detailed questionnaire measured the prevalence, severity, and frequency of 15 digestive symptoms, as well as demographic information, use of medication and medical resources, other illnesses, and dietary habits. The Psychological General Well-Being Index, a self-administered questionnaire, assessed the individual's subjective sense of well-being.
RESULTS: Of the sample population, 28.6% reported substantial symptoms in the preceding 3 months, the majority (111/153 subjects) for >1 yr; 34.1% reported having never experienced significant GI symptoms. The most bothersome symptoms were primarily related to dysmotility-like symptoms in 54.9% of those with chronic symptoms, ulcer-like symptoms in 12.4%, and related to heartburn in 42.5%. Chronic upper GI symptoms were associated with a highly significant (p < 0.001) decrease in all facets of the Psychological General Well Being Index.
CONCLUSIONS: Upper GI symptoms are very prevalent in the general Canadian population and substantially affect the quality-of-life and psychological well-being of those affected. Dysmotility-like symptoms, rather than heartburn, are the most common chronic upper gastrointestinal symptoms in the general population.

Entities:  

Mesh:

Year:  1999        PMID: 10520832     DOI: 10.1111/j.1572-0241.1999.01427.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  38 in total

1.  Is Endoscopy Really Necessary in My Case? A Four Year Retrospective Study.

Authors:  H N Dinesh; Cd Jagadish Kumar; H M Sanjay; V Sachin
Journal:  J Clin Diagn Res       Date:  2015-07-01

2.  Diverging Conclusions from the Same Meta-Analysis in Drug Safety: Source of Data (Primary Versus Secondary) Takes a Toll.

Authors:  Guillermo Prada-Ramallal; Bahi Takkouche; Adolfo Figueiras
Journal:  Drug Saf       Date:  2017-04       Impact factor: 5.606

3.  Comparisons of symptoms reported by elderly and non-elderly patients with GERD.

Authors:  Kenji Furuta; Yoshinori Kushiyama; Kousaku Kawashima; Kotaro Shibagaki; Yoshinori Komazawa; Hirofumi Fujishiro; Naoto Kitajima; Kyoichi Adachi; Yoshikazu Kinoshita
Journal:  J Gastroenterol       Date:  2011-10-08       Impact factor: 7.527

4.  Prevalence of uninvestigated dyspepsia and gastroesophageal reflux disease in Korea: a population-based study using the Rome III criteria.

Authors:  Byung-Hoon Min; Kyu Chan Huh; Hye-Kyung Jung; Young Hoon Yoon; Kee Don Choi; Kyung Ho Song; Bora Keum; Jung Won Kim
Journal:  Dig Dis Sci       Date:  2014-06-13       Impact factor: 3.199

5.  An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group.

Authors:  S J Veldhuyzen van Zanten; N Flook; N Chiba; D Armstrong; A Barkun; M Bradette; A Thomson; F Bursey; P Blackshaw; D Frail; P Sinclair
Journal:  CMAJ       Date:  2000-06-13       Impact factor: 8.262

6.  Digestive symptoms in older adults: prevalence and associations with institutionalization and mortality.

Authors:  Turki Alameel; Mohammed Basheikh; Melissa K Andrew
Journal:  Can J Gastroenterol       Date:  2012-12       Impact factor: 3.522

7.  Helicobacter pylori status among patients undergoing gastroscopy in rural northern Alberta.

Authors:  Isabelle N Colmers-Gray; Ben Vandermeer; Robert I Greidanus; Michael R Kolber
Journal:  Can Fam Physician       Date:  2016-09       Impact factor: 3.275

8.  Comparison of the effects of omeprazole and famotidine in treatment of upper abdominal symptoms in patients with reflux esophagitis.

Authors:  Hiroaki Kusunoki; Masayasu Kusaka; Soichiro Kido; Ryo Yamauchi; Yoshinori Fujimura; Yasuyuki Watanabe; Michio Kobori; Hiroto Miwa; Toshihiko Tomita; Yongmin Kin; Kazutoshi Hori; Nobuo Tano; Kenji Sugimoto; Yoshihiro Nakamura; Kazuma Fujimoto; Noriko Oza; Aki Matsunobu; Naofumi Ono; Seisuke Fuyuno; Yoshikazu Kinoshita; Kyoichi Adachi; Mika Yuki; Tomoo Fujisawa; Ken Haruma
Journal:  J Gastroenterol       Date:  2009-03-13       Impact factor: 7.527

9.  Gastric electrical stimulation: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2006-08-01

10.  The Work Productivity and Activity Impairment Questionnaire for Patients with Gastroesophageal Reflux Disease (WPAI-GERD): responsiveness to change and English language validation.

Authors:  Peter Wahlqvist; Gordon H Guyatt; David Armstrong; Alessio Degl'innocenti; Diane Heels-Ansdell; Samer El-Dika; Ingela Wiklund; Carlo A Fallone; Lisa Tanser; Sander Veldhuyzen van Zanten; Peggy Austin; Alan N Barkun; Naoki Chiba; Holger J Schünemann
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.